Filing Flows › Cardiff Oncology (CRDF) › Q1 2026 › vs Q1 2025
Cardiff Oncology (CRDF) Q1 2026 vs Q1 2025 (year over year)
Cardiff Oncology's revenue fell $68K (-62%) from $109K in Q1 2025 to $41K in Q1 2026.
Cardiff Oncology, Q1 2026: revenue $41K (-62% year over year), net loss $12.3M, operating cash flow −$12.3M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $41K | $109K | −$68K | -62% |
| Other income, net | $505K | $948K | −$443K | -47% |
| Net loss | $12.3M | $13.4M | −$1.1M | -8% |
| Costs & expenses | $12.9M | $14.5M | −$1.6M | -11% |
| Operating costs | $12.9M | $14.5M | −$1.6M | -11% |
| Research & development | $6.8M | $10.5M | −$3.7M | -35% |
| SG&A | $6.1M | $4.0M | $2.1M | +53% |
| Operating cash sources | $14.0M | $14.3M | −$217K | -2% |
| Depreciation | $87K | $93K | −$6K | -6% |
| Share-based compensation | $1.7M | $1.4M | $295K | +22% |
| Cash used in operations | $12.3M | $12.8M | −$506K | -4% |
| Net loss absorbed | $12.3M | $13.4M | −$1.1M | -8% |
| Working capital & other | $1.7M | $818K | $872K | +107% |
Questions
How much did Cardiff Oncology's revenue grow year over year in Q1 2026?
Cardiff Oncology's revenue fell $68K (-62%) from $109K in Q1 2025 to $41K in Q1 2026.